المؤلفون: von Scheidt, M, Bauer, S, Ma, A, Hao, K, Kessler, T, Vilne, B, Wang, Y, Hodonsky, CJ, Ghosh, SKB, Mokry, M, Gao, H, Kawai, K, Sakamoto, A, Kaiser, J, Bongiovanni, D, Fleig, J, Oldenbuettel, L, Chen, Z, Moggio, A, Sager, HB, Hecker, JS, Bassermann, F, Maegdefessel, L, Miller, CL, Koenig, W, Zeiher, AM, Dimmeler, S, Graw, M, Braun, C, Ruusalepp, A, Leeper, NJ, Kovacic, JC, Björkegren, JLM, Schunkert, H

المصدر: medRxiv : the preprint server for health sciences.

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:237546840

المؤلفون: Buck, MC, Bast, L, Hecker, JS, Riviere, J, Rothenberg-Thurley, M, Vogel, L, Wang, DT, Andra, I, Theis, FJ, Bassermann, F, Metzeler, KH, Oostendorp, RAJ, Marr, C, Gotze, KS

المصدر: iScience. 26(8):107328

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:153503813

المؤلفون: Bast, L, Buck, MC, Hecker, JS, Oostendorp, RAJ, Gotze, KS, Marr, C

المصدر: iScience. 24(2):102120

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:146082754

المؤلفون: Winter S; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Götze KS; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany., Hecker JS; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany., Metzeler KH; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany., Guezguez B; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Oncology, University Medical Center Mainz, Mainz, Germany., Woods K; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Oncology, University Medical Center Mainz, Mainz, Germany., Medyouf H; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Frankfurt am Main, Germany., Schäffer A; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Schmitz M; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Wehner R; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Glauche I; Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Roeder I; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Rauner M; Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, and Center for Healthy Aging, University Medical Center, TU Dresden, Dresden, Germany., Hofbauer LC; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Lorenz.Hofbauer@ukdd.de.; Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, and Center for Healthy Aging, University Medical Center, TU Dresden, Dresden, Germany. Lorenz.Hofbauer@ukdd.de., Platzbecker U; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Uwe.Platzbecker@medizin.uni-leipzig.de.; German MDS Study Group (D-MDS), Leipzig, Germany. Uwe.Platzbecker@medizin.uni-leipzig.de.; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany. Uwe.Platzbecker@medizin.uni-leipzig.de.

المصدر: Leukemia [Leukemia] 2024 May; Vol. 38 (5), pp. 936-946. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Clonal Hematopoiesis*/genetics , Stem Cell Niche* , Aging*/genetics , Aging*/physiology, Humans ; Bone Marrow/metabolism ; Bone Marrow/pathology ; Hematopoietic Stem Cells/metabolism ; Hematopoietic Stem Cells/cytology ; Mutation ; Hematologic Neoplasms/genetics ; Hematologic Neoplasms/pathology ; Animals ; Hematopoiesis/genetics

المؤلفون: Dill V; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany., Wagner CV; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany., Keller EC; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Pathology, Technical University of Munich, Munich, Germany., Fernandez-Hernandez FJ; Clinical Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Shoumariyeh K; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium, Partner Site Freiburg, Freiburg, Germany., Odinius TO; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany., Buschhorn L; National Center for Tumor Diseases, Heidelberg, Germany., Hauch RT; Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Suren C; Department of Orthopedics and Sports Orthopedics, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany., Hecker JS; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany., Herhaus P; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany., Sandherr M; Gemeinschaftspraxis Hämato-Onkologie Weilheim, Weilheim, Germany., Schmidt B; Gemeinschaftspraxis Hämato-Onkologie Pasing, Munich, Germany., Slotta-Huspenina J; Institute of Pathology, Technical University of Munich, Munich, Germany., Bassermann F; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany.; Center for Translational Cancer Research (TranslaTUM), Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Höckendorf U; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany., Jilg S; Gemeinschaftspraxis Onkologie Erding, Erding, Germany., Branca C; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany., Vosberg S; Clinical Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Jost PJ; Department of Internal Medicine III, School of Medicine, University hospital rechts der Isar, Technical University of Munich, Munich, Germany.; Clinical Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

المصدر: Blood advances [Blood Adv] 2023 Apr 11; Vol. 7 (7), pp. 1219-1224.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*, Humans ; Cost of Illness ; Receptor-Interacting Protein Serine-Threonine Kinases/metabolism

المؤلفون: Rivière J; Department of Medicine III, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany., Hock J; Department of Medicine III, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany., Buck MC; Department of Medicine III, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany., Hecker JS; Department of Medicine III, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany., Götze KS; Department of Medicine III, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Ismaninger Strasse 22, 81675, Munich, Germany.; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., van der Garde M; Department of Medicine III, School of Medicine, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany. mark.garde@tum.de.; German Cancer Consortium (DKTK), Partner Site Munich, Ismaninger Strasse 22, 81675, Munich, Germany. mark.garde@tum.de.; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. mark.garde@tum.de.

المصدر: Stem cell research & therapy [Stem Cell Res Ther] 2023 Mar 08; Vol. 14 (1), pp. 36. Date of Electronic Publication: 2023 Mar 08.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512 (Electronic) Linking ISSN: 17576512 NLM ISO Abbreviation: Stem Cell Res Ther Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms* , Mesenchymal Stem Cells*, Humans ; Bone Marrow Cells ; Hematopoietic Stem Cells ; Femur Head

المؤلفون: Roas M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Department of Biology II, Human Biology and Bioimaging, LMU Munich, Munich, Germany., Vick B; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; Research Unit Apoptosis in Hematopoietic Stem Cells (AHS), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich, Germany., Kasper MA; Chemical Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin, Berlin, Germany.; Department of Chemistry, Humboldt Universität zu Berlin, Berlin, Germany.; Tubulis GmbH, Munich, Germany., Able M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Polzer H; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; German Cancer Research Centre (DKFZ), Heidelberg, Germany., Gerlach M; Tubulis GmbH, Munich, Germany., Kremmer E; Institute of Molecular Immunology, Helmholtz Zentrum München, German Research Center for Environmental Health, Core Facility Monoclonal Antibodies, Munich, Germany., Hecker JS; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Schmitt S; Tubulis GmbH, Munich, Germany., Stengl A; Department of Biology II, Human Biology and Bioimaging, LMU Munich, Munich, Germany., Waller V; Department of Biology II, Human Biology and Bioimaging, LMU Munich, Munich, Germany., Hohmann N; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Festini M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Ludwig A; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Rohrbacher L; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Department of Translational Cancer Immunology, Gene Center Munich, LMU Munich, Munich, Germany., Herold T; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; German Cancer Research Centre (DKFZ), Heidelberg, Germany., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; Department of Translational Cancer Immunology, Gene Center Munich, LMU Munich, Munich, Germany., Götze KS; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Hackenberger CPR; Chemical Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin, Berlin, Germany.; Department of Chemistry, Humboldt Universität zu Berlin, Berlin, Germany., Schumacher D; Chemical Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin, Berlin, Germany.; Department of Chemistry, Humboldt Universität zu Berlin, Berlin, Germany.; Tubulis GmbH, Munich, Germany., Helma-Smets J; Department of Biology II, Human Biology and Bioimaging, LMU Munich, Munich, Germany.; Tubulis GmbH, Munich, Germany., Jeremias I; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; Research Unit Apoptosis in Hematopoietic Stem Cells (AHS), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich, Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, LMU Munich, Munich, Germany., Leonhardt H; Department of Biology II, Human Biology and Bioimaging, LMU Munich, Munich, Germany.; Tubulis GmbH, Munich, Germany., Spiekermann K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.; German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.

المصدر: Blood [Blood] 2023 Mar 02; Vol. 141 (9), pp. 1023-1035.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology, Humans ; fms-Like Tyrosine Kinase 3/genetics ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Mutation

المؤلفون: Hartmann L; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany.; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hecker JS; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Rothenberg-Thurley M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany., Rivière J; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Jentzsch M; Department of Hematology and Cell Therapy, University Hospital Leipzig (UHL), Leipzig, Germany., Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany., Buck MC; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., van der Garde M; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Fischer L; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden (TUD), Dresden, Germany., Winter S; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden (TUD), Dresden, Germany., Rauner M; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; Center for Healthy Aging, Technical University of Dresden (TUD), Dresden, Germany., Tsourdi E; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; Center for Healthy Aging, Technical University of Dresden (TUD), Dresden, Germany., Weidner H; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; Center for Healthy Aging, Technical University of Dresden (TUD), Dresden, Germany., Sockel K; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden (TUD), Dresden, Germany., Schneider M; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; Department of Hematology and Cell Therapy, University Hospital Leipzig (UHL), Leipzig, Germany., Kubasch AS; Department of Hematology and Cell Therapy, University Hospital Leipzig (UHL), Leipzig, Germany., Nolde M; Orthopedic Center Bogenhausen (OZB), Munich, Germany., Hausmann D; Orthopedic Center Bogenhausen (OZB), Munich, Germany., Lützner J; Department of Orthopedic Surgery, Technical University of Dresden (TUD), Dresden, Germany., Goralski S; Department of Orthopedic Surgery, University Hospital Leipzig (UHL), Leipzig, Germany., Bassermann F; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany., Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany.; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hofbauer LC; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Healthy Aging, Technical University of Dresden (TUD), Dresden, Germany., Schwind S; Department of Hematology and Cell Therapy, University Hospital Leipzig (UHL), Leipzig, Germany., Platzbecker U; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Cell Therapy, University Hospital Leipzig (UHL), Leipzig, Germany., Götze KS; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany. katharina.goetze@tum.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. katharina.goetze@tum.de.; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany. katharina.goetze@tum.de., Metzeler KH; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany. klaus.metzeler@medizin.uni-leipzig.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. klaus.metzeler@medizin.uni-leipzig.de.; Department of Hematology and Cell Therapy, University Hospital Leipzig (UHL), Leipzig, Germany. klaus.metzeler@medizin.uni-leipzig.de.

المصدر: Leukemia [Leukemia] 2022 Nov; Vol. 36 (11), pp. 2647-2655. Date of Electronic Publication: 2022 Sep 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Clonal Hematopoiesis*/genetics , Myeloproliferative Disorders*, Humans ; Hematopoiesis/genetics ; Mutation ; Clone Cells

المؤلفون: Lang JB; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Buck MC; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Rivière J; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Stambouli O; Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany., Sachenbacher K; Department of Physics, Technical University of Munich (TUM), Munich, Germany.; Munich Institute of Biomedical Engineering, Technical University of Munich (TUM), Munich, Germany., Choudhary P; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Dietz H; Department of Physics, Technical University of Munich (TUM), Munich, Germany.; Munich Institute of Biomedical Engineering, Technical University of Munich (TUM), Munich, Germany., Giebel B; Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany., Bassermann F; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany., Oostendorp RAJ; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Götze KS; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany., Hecker JS; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.

المصدر: Frontiers in oncology [Front Oncol] 2022 Oct 03; Vol. 12, pp. 949261. Date of Electronic Publication: 2022 Oct 03 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Braitsch K; Department of Medicine III, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany., Schmalbrock LK; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany., Jung P; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany., Bumeder I; Praxis und Tagesklinik für Hämatologie und internistische Onkologie, Munich, Germany., Kiewe P; Onkologischer Schwerpunkt am Oskar-Helene-Heim, Berlin, Germany., Hecker JS; Department of Medicine III, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany., Verbeek M; Department of Medicine III, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany., Westermann J; Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Clinic, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany., Bullinger L; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Clinic, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.; German Cancer Consortium (DKTK), Partner Sites Berlin/Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany., Keller U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.; German Cancer Consortium (DKTK), Partner Sites Berlin/Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany., Bassermann F; Department of Medicine III, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany.; German Cancer Consortium (DKTK), Partner Sites Berlin/Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Munich, Germany., Krönke J; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany., Götze KS; Department of Medicine III, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany.; German Cancer Consortium (DKTK), Partner Sites Berlin/Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Munich, Germany., Rieger K; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.

المصدر: HemaSphere [Hemasphere] 2022 Aug 09; Vol. 6 (9), pp. e759. Date of Electronic Publication: 2022 Aug 09 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE